您的位置: 首页 > 农业专利 > 详情页

binding protein nkg2d, cd16 and ror1 or ror2
专利权人:
INC.;DRAGONFLY THERAPEUTICS
发明人:
ANN F. CHEUNG,BIANKA PRINZ,BRADLEY M. LUNDE,GREGORY P. CHANG,WILLIAM HANEY
申请号:
BR112019024654
公开号:
BR112019024654A2
申请日:
2018.05.22
申请国别(地区):
BR
年份:
2020
代理人:
摘要:
the invention relates to proteins that bind to the nnkg2d, cd16 and ror1 or ror1 receptor or a tumor-associated antigen, as well as pharmaceutical compositions and therapeutic methods useful in the treatment of several specific binding cancer.a invenção refere-se a proteínas que se ligam ao receptor nnkg2d, cd16 e ror1 ou ror2 um antígeno associado a tumores, bem como composições farmacêuticas e métodos terapêuticos úteis no tratamento do cancro de ligação específica de vários.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充